Organogenesis Holdings (ORGO) Accumulated Expenses (2015 - 2026)

Organogenesis Holdings' Accumulated Expenses history runs 12 years deep, the most recent figure standing at $37.7 million for Q1 2026.

• On a quarterly basis, Accumulated Expenses rose 21.03% year-over-year to $37.7 million in Q1 2026; TTM through Mar 2026 was $37.7 million, a 21.03% increase from a year earlier, with the FY2025 full-year figure at $49.5 million, up 25.55% from the prior year.
• Accumulated Expenses eased to $37.7 million in Q1 2026 per ORGO's latest filing, from $49.5 million in the prior quarter.
• Across five years, Accumulated Expenses topped out at $49.5 million in Q4 2025 and bottomed at $26.3 million in Q2 2025.
• The 5-year median for Accumulated Expenses is $35.0 million (2023), against an average of $34.8 million.
• Across the five-year window, Accumulated Expenses surged 39.03% in 2024 and tumbled 30.69% in 2025, its largest moves.
• Year by year, Accumulated Expenses stood at $26.4 million in 2022, then increased by 13.71% to $30.1 million in 2023, then soared by 31.19% to $39.5 million in 2024, then increased by 25.55% to $49.5 million in 2025, then declined by 23.92% to $37.7 million in 2026.
• Per Business Quant, the three latest ORGO Accumulated Expenses figures stand at $37.7 million (Q1 2026), $49.5 million (Q4 2025), and $40.3 million (Q3 2025).